Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Manna is a natural medicinal substance consisting of the dried saccharine exudate obtained from the trunk of the manna ash, *Fraxinus ornus*. Its primary active constituent is mannitol, a sugar alcohol (polyol) that typically comprises 40% to 90% of the exudate's mass, alongside other sugars such as glucose, fructose, and oligosaccharides like mannotetrose. Manna has historically been employed as a mild osmotic laxative and a sweetener for diabetic patients. Its pharmacological action is primarily attributed to the osmotic properties of mannitol; when ingested, it remains largely unabsorbed in the gastrointestinal tract, creating an osmotic gradient that draws water into the intestinal lumen. This increase in intraluminal pressure and fluid volume promotes bowel motility and facilitates evacuation. Although its use in mainstream medicine has largely been replaced by purified mannitol and other synthetic osmotic agents, it remains a recognized natural product in various pharmacopeias and is still utilized in certain traditional and herbal medicinal preparations, particularly for pediatric constipation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on manna.